Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
PUT
Sherwin-Williams
SHW
$87.4B
| $364K | ﹤0.01% |
2,400
-3,300
| -58% | -$489K |
|
|
TGP
4452
PUT
DELISTED
Teekay LNG Partners L.P.
TGP
| $364K | ﹤0.01% |
21,800
-3,400
| -13% | -$54.4K |
|
|
GRA
4453
PUT
DELISTED
W.R. Grace & Co.
GRA
| $364K | ﹤0.01% |
5,100
-28,800
| -85% | -$2.08M |
|
4454
CALL
Masco
MAS
$14.7B
| $362K | ﹤0.01% |
9,900
-16,400
| -62% | -$631K |
|
|
BELFB
4455
Bel Fuse Inc Class B
BELFB
$4.25B
| $361K | ﹤0.01% |
13,607
+9,779
| +255% | +$244K |
|
4456
Enphase Energy
ENPH
$5.39B
| $361K | ﹤0.01% |
74,488
+68,138
| +1,073% | +$373K |
|
|
BPL
4457
CALL
DELISTED
Buckeye Partners, L.P.
BPL
| $361K | ﹤0.01% |
10,100
+5,400
| +115% | +$193K |
|
|
LLL
4458
PUT
DELISTED
L3 Technologies, Inc.
LLL
| $361K | ﹤0.01% |
1,700
-200
| -11% | -$41.6K |
|
4459
Lindblad Expeditions
LIND
$2.24B
| $360K | ﹤0.01% |
24,203
+11,511
| +91% | +$163K |
|
4460
Manitowoc
MTW
$727M
| $360K | ﹤0.01% |
14,991
+10,360
| +224% | +$253K |
|
4461
CALL
Pentair
PNR
$10.5B
| $360K | ﹤0.01% |
8,300
+4,400
| +113% | +$191K |
|
|
NIHD
4462
DELISTED
NII Holdings, Inc. Common Stock
NIHD
| $360K | ﹤0.01% |
61,430
+54,911
| +842% | +$282K |
|
4463
OR Royalties Inc
OR
$6.31B
| $359K | ﹤0.01% |
47,239
+40,600
| +612% | +$347K |
|
|
SRNE
4464
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $359K | ﹤0.01% |
81,515
+44,436
| +120% | +$246K |
|
4465
Liberty Energy
LBRT
$3.52B
| $358K | ﹤0.01% |
16,594
+15,508
| +1,428% | +$300K |
|
|
SPWR
4466
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $358K | ﹤0.01% |
74,976
-27,791
| -27% | -$132K |
|
|
CBLK
4467
DELISTED
Carbon Black, Inc. Common Stock
CBLK
| $358K | ﹤0.01% |
16,915
+11,467
| +210% | +$269K |
|
4468
PUT
Boston Properties
BXP
$10.8B
| $357K | ﹤0.01% |
2,900
-4,900
| -63% | -$624K |
|
4469
PUT
Huntington Bancshares
HBAN
$36.1B
| $357K | ﹤0.01% |
23,900
-22,300
| -48% | -$349K |
|
4470
HCI Group
HCI
$2.28B
| $357K | ﹤0.01% |
8,164
+1,113
| +16% | +$46.1K |
|
4471
CALL
Unilever
UL
$135B
| $357K | ﹤0.01% |
5,778
-3,111
| -35% | -$196K |
|
4472
Ascendis Pharma A/S
ASND
$16.8B
| $356K | ﹤0.01% |
5,020
+137
| +3% | +$9.43K |
|
|
STEL
4473
DELISTED
Stellar Bancorp
STEL
| $356K | ﹤0.01% |
10,045
+6,279
| +167% | +$227K |
|
|
UBNK
4474
DELISTED
United Financial Bancorp, Inc.
UBNK
| $356K | ﹤0.01% |
21,226
+17,514
| +472% | +$308K |
|
4475
CRA International
CRAI
$1.07B
| $355K | ﹤0.01% |
7,043
+1,734
| +33% | +$94.6K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.